EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kiromic BioPharma's enterprise value is $14.84 Mil.
Kiromic BioPharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Kiromic BioPharma's EV-to-Revenue for today is .
The historical rank and industry rank for Kiromic BioPharma's EV-to-Revenue or its related term are showing as below:
KRBP's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.17 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Kiromic BioPharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kiromic BioPharma's EV-to-Revenue
For the Biotechnology subindustry, Kiromic BioPharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kiromic BioPharma's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kiromic BioPharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Kiromic BioPharma's EV-to-Revenue falls into.
Kiromic BioPharma's current Enterprise Value is $14.84 Mil.
Kiromic BioPharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiromic BioPharma's share price for today is $3.23.
Kiromic BioPharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiromic BioPharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Kiromic BioPharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kiromic BioPharma (Kiromic BioPharma) Business Description
Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRBP has been successfully added to your 